Friday, July 24, 2015

Faruqi & Faruqi Investigation: Thoratec Corp.

Faruqi & Faruqi, LLP Announces the Investigation of Thoratec Corp. (THOR) Over the Proposed Sale of the Company to St. Jude Medical Inc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Thoratec Corp. (“Thoratec” or the “Company”) (NASDAQGS:THOR) for potential breaches of fiduciary duties in connection with the sale of the Company to St. Jude Medical Inc. for approximately $3.4 billion.
The Company’s stockholders will only receive $63.50 for each share of Company common stock they own. The offer represents a mere 10 percent premium over Thortec's Friday, July 17th, closing price per share and a negligible premium over Thortec's Wednesday, July 22nd, opening price per share. Furthermore, the Company’s price per share is expected to continue climbing.
If you own common stock in Thoratec and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact F&F's Juan E. Monteverde, Esq. either via e-mail at or by telephone at (877) 247-4292 or (212) 983-9330. 

No comments:

Post a Comment